基于泛癌分析的预后标记物,以抑制乳腺癌的进展
Jinfeng Zhao1, Wanquan Chen1, Longpeng Li1
1Institute of Physical Education and Sport, Shanxi University, Taiyuan 030006, China.
Genes
|September 27, 2025
概括
免疫球蛋白连接链 (JCHAIN) 是潜在的泛癌诊断和预后标志物. JCHAIN通过IL-2/STAT4通路影响乳腺癌的进展,抑制瘤迁移和入侵.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 免疫球蛋白链链 (JCHAIN) 在癌症和免疫调节中的作用在很大程度上是未知的.
- JCHAIN是一种多重的IgA和IgM连接链.
研究的目的:
- 为了对JCHAIN进行全面的泛癌分析.
- 确定JCHAIN的表达特征,预后意义,免疫透和恶性瘤中的功能.
主要方法:
- 对基因和蛋白质表达数据的全癌症分析.
- 使用考克斯回归和卡普兰-梅尔的预后分析.
- 使用TISIDB和TIMER进行免疫透分析.
- 单细胞和空间转录组分析.
- 通过cBioPortal和UALCAN进行突变和甲基化分析.
- 使用KEGG,GSEA和体外实验的功能分析.
主要成果:
- 在不同癌症中,JCHAIN表达有很大差异,高表达与良好的预后相关.
- JCHAIN与免疫相关的基因,免疫细胞,甲基化和突变有关.
- 在乳腺癌中,JCHAIN与干性负相关,并抑制迁移/入侵.
- 丰富分析涉及JCHAIN在免疫反应,B细胞激活和JAK-STAT信号传递中.
结论:
- JCHAIN作为各种癌症的潜在诊断和预后标记.
- JCHAIN通过IL-2/STAT4信号通路影响乳腺癌的进展.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K


